Blackstone closes $6.3bn life sciences fund
Blackstone Inc has raised $6.3bn for its latest life-sciences fund, Blackstone Life Sciences VI, marking the firm’s largest capital raise for backing late-stage clinical trials of drugs and medical technologies, according to a report by Bloomberg.